Deferred Income Tax Expense (Benefit) of Theravance Biopharma, Inc. from 31 Dec 2012 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Theravance Biopharma, Inc. quarterly and annual Deferred Income Tax Expense (Benefit) in USD history and change rate from 31 Dec 2012 to 31 Mar 2025.
  • Theravance Biopharma, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending 31 Mar 2025 was $1,852,000, a 261% decline year-over-year.
  • Theravance Biopharma, Inc. annual Deferred Income Tax Expense (Benefit) for 2024 was $7,573,000, a 336% decline from 2023.
  • Theravance Biopharma, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $3,207,000.
  • Theravance Biopharma, Inc. annual Deferred Income Tax Expense (Benefit) for 2017 was $0.
Source SEC data
View on sec.gov
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Change (%)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Change (%)

Theravance Biopharma, Inc. Quarterly Deferred Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $1,852,000 -$1,339,000 -261% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q1 2024 $513,000 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1

Theravance Biopharma, Inc. Annual Deferred Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $7,573,000 -$10,780,000 -336% 01 Jan 2024 31 Dec 2024 10-K 07 Mar 2025 2024 FY
2023 $3,207,000 01 Jan 2023 31 Dec 2023 10-K 07 Mar 2025 2024 FY
2017 $0 $0 01 Jan 2017 31 Dec 2017 10-K 28 Feb 2018 2017 FY
2016 $0 $0 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2018 2017 FY
2015 $0 $0 01 Jan 2015 31 Dec 2015 10-K 28 Feb 2018 2017 FY
2014 $0 $0 01 Jan 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
2013 $0 $0 01 Jan 2013 31 Dec 2013 10-K 11 Mar 2016 2015 FY
2012 $0 01 Jan 2012 31 Dec 2012 10-K 13 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.